గాల్ బ్లాడర్ క్యాన్సర్

Evidence suggests distinct models of molecular and pathologic progression, and a growing body of genetics data points to a heterogeneous collection of underlying mutations in key oncogenes and tumor suppressor genes. Although tumor genetics have been used to tailor individual treatment regimens and guide clinical decision making in other cancers, these principles have not been applied in gallbladder malignancy. Recent clinical trials with targeted therapies seem promising, although the relationships between subsets of patients with positive responses to therapy and tumor genetics remain unexpl…

స్పాన్సర్: బనారస్ హిందూ యూనివర్సిటీ
ClinicalTrials.gov లో NCT05404347
రిజిస్ట్రీలో చివరి అప్‌డేట్ 13 Aug 2024 · మేము చదివినది 20 Oct 2026